Kymera Therapeutics (KYMR) Total Non-Current Liabilities (2020 - 2024)
Kymera Therapeutics' Total Non-Current Liabilities came in at $142.42 million for Q4 2024, down 21.2% from $180.79 million a year earlier.
Powered by 
Analysis
Kymera Therapeutics (KYMR) Total Non-Current Liabilities (2020 - 2024) Analysis & Trends
Going back to Q4 2020, Kymera Therapeutics' Total Non-Current Liabilities data covers 14 quarters.
- Total Non-Current Liabilities carries a four-year compound annual growth rate of -8.5% (FY2020 to FY2024).
- Going back by year, Total Non-Current Liabilities was $180.79 million in FY2023 (+60.4%), $112.74 million in FY2022 (-22.9%), $146.2 million in FY2021 (-28.0%) and $203.19 million in FY2020.
- The Q4 2024 figure represents the lowest quarterly Total Non-Current Liabilities since Q4 2022.
- Year-over-year, Total Non-Current Liabilities increased in four of the last five quarters, with growth averaging 18.8%.
- The fastest year-over-year change in Total Non-Current Liabilities over five years came in Q4 2023 (growth of 60.4%), and the weakest in Q1 2022 (a decline of 29.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.92 Bn |
| 10 | Kymera Therapeutics | 9.25 Bn | 6.56 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 142.42 Mn |
| Dec 31, 2023 | 180.79 Mn |
| Sep 30, 2023 | 156.84 Mn |
| Jun 30, 2023 | 146.29 Mn |
| Mar 31, 2023 | 151.66 Mn |
| Dec 31, 2022 | 112.74 Mn |
| Sep 30, 2022 | 125.33 Mn |
| Jun 30, 2022 | 125.21 Mn |
| Mar 31, 2022 | 134.07 Mn |
| Dec 31, 2021 | 146.20 Mn |
| Sep 30, 2021 | 159.24 Mn |
| Jun 30, 2021 | 176.20 Mn |
| Mar 31, 2021 | 189.21 Mn |
| Dec 31, 2020 | 203.19 Mn |
API Access
Kymera Therapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=KYMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "KYMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=KYMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();